FDA Approves GLP-1 Drugs for Fatty Liver Disease With 63% Success Rate
New clinical trials show GLP-1 medications like Ozempic can reverse fatty liver disease in up to 62% of patients within 72 weeks.
20 articles
New clinical trials show GLP-1 medications like Ozempic can reverse fatty liver disease in up to 62% of patients within 72 weeks.
Retatrutide shows unprecedented weight loss results in phase 3 trials, but higher side effects may limit its advantage over existing medications.
Brian Johnson's tirzepatide experiment sparked interest in microdosing GLP-1s for anti-aging, but evidence remains hypothetical with real risks.
Thomas DeLauer explains how magnesium deficiency disrupts insulin function and shares a 5-step protocol to restore metabolic health.
Large-scale analysis of 63 trials shows melatonin improves cardiovascular markers despite alarming 2025 study headlines.
Research reveals how this ancient spice's unique amino acid helps regulate insulin naturally without dangerous blood sugar crashes.
New research reveals that robust insulin production after eating actually reduces disease risk, contrary to popular belief.
New research reveals why high-intensity interval training outperforms moderate cardio for insulin sensitivity.
Science-backed protocols for HIIT, circadian eating, and sleep optimization to dramatically improve glucose regulation and longevity.
Latest meta-analysis of 34 trials shows taurine improves blood sugar, cholesterol, and inflammation markers despite recent aging debates.
Siim Land megadosed melatonin at 100x normal levels to test its potential anti-aging and antioxidant effects beyond sleep.
Dr. Brad Stanfield shares his 4-year journey funding a rapamycin clinical trial, including personal financial sacrifices and business challenges.
TARGET-D trial shows 52% reduction in repeat heart attacks when vitamin D levels are optimized above 40 ng/mL in cardiac patients.
Large clinical trial shows artificial sweeteners may help maintain weight loss and boost beneficial gut bacteria production.
New research reveals how liver-focused strategies can improve insulin sensitivity while still eating carbohydrates.
A large study suggests melatonin increases heart failure risk, but critical methodology problems may invalidate the alarming findings.
New FDA-approved blood test can rule out Alzheimer's with 98% accuracy, but positive results are only 22% reliable.
New research reveals how meal timing during night shifts dramatically affects glucose tolerance and cardiovascular risk markers.
First new COPD medication in over a decade targets dual pathways to improve breathing and reduce inflammation.
Dr. Eran Elinav reveals how gut microbiome timing affects metabolic health and why personalized nutrition matters more than generic dietary advice.